279 related articles for article (PubMed ID: 23195389)
1. A psychometric validation of two brief measures to assess palliative need in patients severely affected by multiple sclerosis.
Sleeman KE; Higginson IJ
J Pain Symptom Manage; 2013 Sep; 46(3):406-12. PubMed ID: 23195389
[TBL] [Abstract][Full Text] [Related]
2. Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Giovannetti AM; Pietrolongo E; Giordano A; Cimino V; Campanella A; Morone G; Fusco A; Lugaresi A; Confalonieri P; Patti F; Grasso MG; Ponzio M; Veronese S; Solari A
Qual Life Res; 2016 Nov; 25(11):2755-2763. PubMed ID: 27125955
[TBL] [Abstract][Full Text] [Related]
3. Screening for depression in advanced disease: psychometric properties, sensitivity, and specificity of two items of the Palliative Care Outcome Scale (POS).
Antunes B; Murtagh F; Bausewein C; Harding R; Higginson IJ;
J Pain Symptom Manage; 2015 Feb; 49(2):277-88. PubMed ID: 25131889
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.
Gao W; Crosby V; Wilcock A; Burman R; Silber E; Hepgul N; Chaudhuri KR; Higginson IJ;
PLoS One; 2016; 11(10):e0165379. PubMed ID: 27780237
[TBL] [Abstract][Full Text] [Related]
5. Use of the palliative outcome scale in Argentina: a cross-cultural adaptation and validation study.
Eisenchlas JH; Harding R; Daud ML; Pérez M; De Simone GG; Higginson IJ
J Pain Symptom Manage; 2008 Feb; 35(2):188-202. PubMed ID: 18082359
[TBL] [Abstract][Full Text] [Related]
6. The reliability and validity of pain interference measures in persons with multiple sclerosis.
Osborne TL; Raichle KA; Jensen MP; Ehde DM; Kraft G
J Pain Symptom Manage; 2006 Sep; 32(3):217-29. PubMed ID: 16939846
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained.
Higginson IJ; Costantini M; Silber E; Burman R; Edmonds P
Postgrad Med J; 2011 Nov; 87(1033):769-75. PubMed ID: 21978993
[TBL] [Abstract][Full Text] [Related]
8. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
Gray O; McDonnell G; Hawkins S
Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
[TBL] [Abstract][Full Text] [Related]
9. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group.
Hearn J; Higginson IJ
Qual Health Care; 1999 Dec; 8(4):219-27. PubMed ID: 10847883
[TBL] [Abstract][Full Text] [Related]
11. Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients.
Pukrittayakamee P; Sapinum L; Suwan P; Harding R
J Pain Symptom Manage; 2018 Sep; 56(3):414-420. PubMed ID: 29885457
[TBL] [Abstract][Full Text] [Related]
12. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
[TBL] [Abstract][Full Text] [Related]
13. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA
Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patient-reported outcome measures in multiple sclerosis.
Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C
Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571
[TBL] [Abstract][Full Text] [Related]
15. Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Lucas-Carrasco R; Sastre-Garriga J; Galán I; Den Oudsten BL; Power MJ
Disabil Rehabil; 2014; 36(12):1001-5. PubMed ID: 23962197
[TBL] [Abstract][Full Text] [Related]
16. Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Magistrale G; Pisani V; Argento O; Incerti CC; Bozzali M; Cadavid D; Caltagirone C; Medori R; DeLuca J; Nocentini U
Mult Scler; 2015 Apr; 21(4):448-56. PubMed ID: 25092769
[TBL] [Abstract][Full Text] [Related]
17. Apathy in multiple sclerosis: a validation study of the apathy evaluation scale.
Raimo S; Trojano L; Spitaleri D; Petretta V; Grossi D; Santangelo G
J Neurol Sci; 2014 Dec; 347(1-2):295-300. PubMed ID: 25455303
[TBL] [Abstract][Full Text] [Related]
18. Self-rating makes the difference: identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Strupp J; Golla H; Galushko M; Buecken R; Ernstmann N; Hahn M; Pfaff H; Voltz R
Palliat Support Care; 2015 Jun; 13(3):733-40. PubMed ID: 24849300
[TBL] [Abstract][Full Text] [Related]
19. Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale.
Harding R; Selman L; Agupio G; Dinat N; Downing J; Gwyther L; Mashao T; Mmoledi K; Moll T; Sebuyira LM; Panjatovic B; Higginson IJ
Health Qual Life Outcomes; 2010 Jan; 8():10. PubMed ID: 20100332
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.
Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
Mult Scler; 2003 Aug; 9(4):411-9. PubMed ID: 12926848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
